Member Info for rivaldo

Very encouraging info posted elsewhere (by Celeritas) about the new license and distribution deal in the United States for Gelclair and VLG's partner Jaguar Health.

Jaguar Health is expanding its focus to include cancer-related supportive care, with Gelclair being a foundational element in this strategy.

Https://in.investing.com/news/jaguar-health-names-new-svp-of-growth-strategy-93CH-4133486

Jaguar's stock rocketed 44% "after the pharmaceutical company announced a new license for a chemo mouth treatment", i.e Gelclair:

Https://investorplace.com/2024/04/why-is-jaguar-health-jagx-stock-up-44-today/

And:

Https://jaguarhealth.gcs-web.com/news-releases/news-release-details/jaguar-health-appoints-biopharmaceutical-industry-veteran

Good to see 30,000 shares bought this morning in three tranches, at steadily increasing buying prices up to 89.75p.

Https://www.proactiveinvestors.co.uk/companies/news/1045809/accesso-has-50-upside-according-to-broker-1045809.html

"Accesso has '50% upside' according to broker

Published: 13:34 22 Apr 2024 BST

Accesso Technology Group PLC (AIM:ACSO, OTC:LOQPF) should see positive margin impacts emerging from a focus on higher-quality revenue streams, says house broker Shore Capital.

“The market opportunity appears promising spanning across various venues and geographies, and we see ACSO as well place to capture a greater share through leveraging its now broader solutions suite”.

“We do not believe the current valuation reflects these positive trends, noting our fair value sees +50% upside on a low/mid-teens EV/cash EBITDA multiple,”

'Buy' is the broker’s recommendation for the virtual ticketing and queuing specialist."

New appointment - interesting detail about the new AI-enabled safety tech:

Https://news.railbusinessdaily.com/petards-rail-bolsters-team-with-new-appointment/

"Petards Rail bolsters team with new appointment

April 22, 2024

Leading provider of intelligent train technology, Petards Rail has appointed Calvin Fahey to the role of procurement manager.

Calvin is Level 3 Chartered Institute of Procurement and Supply (CIPS) certified and brings with him near a decade’s worth of experience within procurement-related roles.

In his role at Petards Rail, Calvin will spearhead the company’s procurement team and processes, ensuring the timely and cost-effective acquisition of materials and services.

Petards Rail designs and delivers train technology to help companies within the rail industry maximise passenger safety, optimise train performance and meet ever increasing passenger and industry demands. Its technology includes forward facing and rear facing cameras, track debris cameras, an on-train camera/monitor system, Automatic Selective Door Operation, interior cameras and pantograph surveillance cameras. In addition, the company offers supporting services and a back-office software, eyeTrain Connect.

In the latter half of 2023, the company launched its PTeye solution which, incorporating the latest in AI-ready technology, was developed to prevent trap and drag incidents before train dispatch and, as a secondary safety measure, to detect drag.

At this time, the company also strengthened its team with the appointment of Jack Teichman to the role of rail engineer. An experienced mechanical design engineer, Jack joined Petards Rail having held a breadth of engineering roles such as product engineer, configuration engineer and outfit engineer, across a variety of industries including defence and electricals.

Speaking of his appointment, Calvin said: “I am thrilled to join Petards Rail as procurement manager. The company’s commitment to customer service and developing high-calibre intelligent rail solutions, made it an easy decision.

“I enjoy using data to inform continuous improvement, be it cost reductions, optimising supplier relationships or implementing more efficient procurement processes. I am looking forward to applying this in my role at Petards Rail and contributing to the success of a dynamic company.”

Victoria Hodge, general manager of Petards Rail, said: “I am delighted to announce the addition of Calvin to the Petards Rail team. His wealth of expertise and dedication to quality and continuous improvement align perfectly with our company values.

“It is an exciting time for Petards Rail marked by our recent win at the SPOTLIGHT awards and the launch of our new lifesaving technology. It is great to have Calvin on this journey with us.”

With decades of experience in the rail industry, Petards Rail has worked with organisations throughout the sector, from rolling stock companies to train operators

Excellent news, particularly being the first use of Globe to locate porphyry copper.

Hopefully this will lead to further contracts from the rest of the six participants in the BHP Xplor 2024 accelerator programme - GTC have already obtained work from Asian Battery Minerals, who are another participant.

CAPD have a new institutional investor - Rockwood Strategic disclosed as follows in their recent monthly factsheet for last month:

Https://d1bcjbyi5yiron.cloudfront.net/app/uploads/2024/04/Factsheet-Q1-2024.pdf

"We purchased two new holdings this quarter.....Secondly we bought Capital Limited. This business has grown consistently, building a world leading position in the provision of drilling services to Mining companies. Asset rich, it has, over time, diversified by geography and client, breaking into the majors, such as Barrick. It has an unparalleled safety record, and been developing a Laboratory services business which is totally ignored in the valuation of the shares on a ‘24 PE of 6.2x and EV/Ebitda 4x. Equity owning, proven management should address this in time. We believe its ‘hue’ of resources has created a blind spot for generalist investors."

A very encouraging trading statement, and way ahead of Cavendish's expectations:

- £9.8m revenues compared to £9.0 forecast

- £5.4m cash pile compared to £4.2m forecast

- gross profit of over £6m compared to £5.6m forecast

- positive EBITDA compared to break-even forecast

Plus this year "has started well with good momentum going into the first quarter with a healthy order book".

Pretty good for a £9.1m m/cap company at 3.85p

Molendotech are trialling their Bacterisk kit with the West Country Rivers Trust. This reads well:

“If successful, the methodology can be rolled out to other UK Rivers Trusts.”

Https://wrt.org.uk/innovative-river-test-for-unseen-health-risks/

QTS have won substantial new contracts with Network Rail:

Https://www.qtsgroup.com/qts-wins-north-west-and-central-capital-delivery-works/

"QTS Group is among the winners of Network Rail’s nearly £2bn capital works delivery frameworks for CP7 in the North West and Central region.

The leading railway contractor has won Civil Engineering Lot B (Renewals design and build) and Lot C (Renewals build only) in the North West and, covering the entire North West & Central region, Civil Engineering Lot D (Reactive) with On-call provision."

And J Browne have won further work with Thames Water.

Https://www.linkedin.com/posts/j-browne-construction-ltd_engineering-infrastructure-water-activity-7186633615919710210-YZyY?utm_source=share&utm_medium=member_android

"We are pleased to announce that Browne has been awarded the Surbiton trunk mains renewal works by Thames Water as part of the wider FA1488 PROG2011 Trunk Mains Programme"

CAPD's holding in WIA Gold has risen another 12% overnight (after a successful fundraising) to new highs at $AD0.098 - it's now worth £9.3m:

Https://www.asx.com.au/markets/company/wia

Placing done nice and smoothly, and hardly a surprise given the significant shareholdings of the three major holders - which remain extremely weighty at 33% of the company.

Given the apparent demand it's possible that the share price will stick at the 240p mark or even higher, but whatever the case I suspect it will remain pretty strong.

Especially given the signal given the by the 907,000 share buyback at the same price, with those shares now quickly cancelled.

Good to see the new RCF now agreed - and also (as previewed by whythefuss!):

"New Partner in USA

The Company also announces that it has finalised an exclusive long-term license and distribution deal in the United States for Gelclair, an FDA-approved oral mucositis prescription product, with Jaguar Health (NASDAQ:JAGX). This agreement, spanning 5 years, entails license fees, royalties, and product revenue payments to the Company.

"We are really pleased to have partnered Gelclair in the USA, a market where Gelclair has been present for many years," said Jerry Randall, CEO of VLG. "This new agreement will ensure the continued supply of Gelclair to US oncology patients suffering oral mucositis, and generate meaningful additional revenues for the Company in the future."

Https://uk.advfn.com/stock-market/london/venture-life-VLG/share-news/Venture-Life-Group-PLC-RCF-in-Place-and-New-Partner-in-the-USA/93683690

Indeed Lesville, a very encouraging performance today given both the usual trend on results day and especially going ex-div too.

Interesting little 8,776 buy at 95.4p reported late as well.

Tamesis Partners reiterate their 160p target price and forecast 18.7c EPS this year, or exactly 15p EPS.

They summarise:

"Investments.

Total value of investments (listed and unlisted) was $51.7m as at 31 March 2024 up from ($47.2m) at as 31 December 2023). Strong growth in the investments over the quarter, driven by the gold rally as a majority of the investments are gold companies (namely Allied Gold, Predictive Discovery and WIA Gold). Predictive released their long awaited PFS this week, and WIA announced an updated MRE with a 63% increase in contained gold at their Kokoseb asset in Namibia

• Outlook.

Revenue guidance has been re-iterated at $355-375m. We expect strong improved performance across Drilling and MSALABs, while Mining is ticking along as expected. The Sukari kit has the ability to be redeployed and deliver step changes to the P&L, while the elevated commodity prices sets the scene for further potential drilling contracts. We maintain our current revenue estimate of $358m.

Investment Case

We remain positive on the outlook for a strong operational performance through 2024. Key growth projects in the Capital business are ramping well, projects continue to be won with high quality clients and rigs are being mobilised to higher quality contracts.

MSALABS is developing momentum, both at their NGM labs contract and their partnership with Barrick. The mining services business has the potential for another big contract. The company is trading on EV/EBITDA and PE multiples for FY24 of 2.4x and 6.2x, and for FY25 2.2x and 5.4x, while delivering a dividend yield of 3.4%. We remain comfortable with our 160p PT."

Agreed Lesville. Today's update shows a steady as she goes Q1, ready for the big contracts commencing this Q2 at Belinga, Reqo Diq and Nevada.

Good to see guidance for the year being reiterated, and ARPOR increased markedly to an impressive $202,000. Excellent year on year growth at MSALabs/Chrysos and at Mining offset a little Q1 weakness in Drilling.

The picture for this quarter onwards remains excellent, with Q1 generally being a weaker quarter, whilst traders who bought recently will no doubt consider this quarter's results weren't exciting enough for them.

Stifel state "1Q24 Sets Foundation for Strong 2024".

But subscription-only so no further detail:

Https://twitter.com/research_tree/status/1780851311400858091

In relation to the rising gold price, CAPD will benefit from not only the substantial additional revenues accruing to mining companies, which will benefit mining production expansion programmes and encourage drilling for new resources, but also the increased certainty as regards exploring in new geographies and regions.

WH Ireland's 140p valuation seems quite conservative imo.

With a cash pile of 37p per share, and 10p EPS forecast this year, a 140p share price would put TST on an ex-cash P/E of only 10.3.

Given this record of PBT and EPS I'd say that multiple is perfectly reasonable.

And the PEG is just 0.28, which is ludicrously cheap:

2021 - £0.2m PBT

2022 - £0.4m PBT

2023 - £0.7m PBT

2024 - £1.0m PBT (forecast)

And for EPS:

2021 - 4.0p

2022 - 6.6p

2023 - 7.6p

2024 - 10.0p (forecast)

WH Ireland today reiterated their 140p price target (increased recently from 120p).

They summarise:

"Full year results: Recurring revenue strategy delivers further profit growth

Touchstar is a supplier of mobile data computing solutions and managed services to a variety of industrial sectors. This morning’s full year results reflect the outcome of a multiyear strategy coming to fruition for the group, with recurring revenue growth of 8.7% delivering overall revenue growth of 7.1% and in turn a 60% increase in PBT to £0.7m.

Over the past few years, Touchstar has focused on enhancing the returns from their product offering through a shift towards recurring software license and hardware maintenance revenues, whilst also charging a fair rate for customer requested software updates. Each of these strands continued to grow in excess of overall revenue growth in FY2023, delivering further improvement in gross margin, reaching 63.6% in H2 2023 up 19bp from 61.7% in FY2022A.

With FY2024E reported to have started to plan, we expect this strategy to drive further organic growth in the coming years, with additional potential for expansion into new overseas markets and strategic M&A.

Trading on an FY2024E PE of 9.5x and EV/EBITDA of just 2.6x, underpinned by £3.0m of net cash (37.5% of market cap), we see scope for the shares to continue to move higher as further growth is delivered. We see fair value at 140p."

"WHI view:

With recurring revenues reaching a new high of 40.4% in the period, we are encouraged by further progress against the group’s strategic aims and believe this should help drive continued organic revenue and profit growth in future years. With the potential from new overseas markets, product improvements, and M&A, we see scope for the shares to continue to move higher as further growth is delivered. We see fair value for the shares at 140p."

Hello - 50,000 shares just bought at 95.34p, well above the 94p offer. Very keen.

Hardly surprising with the gold price now at $2,387.

Perhaps a little buying has been coming in on the back of the overnight news that the UK's largest train factory owned by Alstom (a PEG customer) has been saved with a government order of ten commuter trains...

Https://www.express.co.uk/news/uk/1889256/alstom-train-manufacturer-saved-transport-secretary-deal

TST's recent history and profitable turnaround is worth recording. WH Ireland's numbers are as follows:

2021 - £0.2m PBT

2022 - £0.4m PBT

2023 - £0.7m PBT

2024 - £1.0m PBT (forecast)

And for EPS:

2021 - 4.0p

2022 - 6.6p

2023 - 7.6p

2024 - 10.0p (forecast)

I'd say this is rather impressive progress! And all now backed up by the £3m cash pile and 40% recurring income.